78 results
8-K
EX-1.1
APLS
Apellis Pharmaceuticals Inc
1 Nov 23
Entry into a Material Definitive Agreement
7:59am
and the Prospectus.
(gg) The Company and each of its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
424B5
f5y646tb z0efm4o2
1 Nov 23
Prospectus supplement for primary offering
7:51am
8-K
EX-10.1
o7np5
2 Aug 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.1
d5p2app srlyvcjr0jqj
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
8-K
EX-1.1
ny7lh7i2jhug
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
424B5
7txpo u46z6
24 Mar 22
Prospectus supplement for primary offering
8:02pm
424B5
4l0le22vzabz1t bxanq
23 Mar 22
Prospectus supplement for primary offering
5:14pm